Salvador Plasencia, the lead doctor who sold Matthew Perry liquid ketamine before the actor’s overdose, was sentenced to 30 months in prison.

Ketamine, the powerful sedative that caused actor Matthew Perry's 2023 drug overdose death, has been approved for clinical use as an anesthetic since 1970, when it was first given to wounded American ...

The Melt acquisition expands Harrow’s portfolio and underscores its commitment to innovative therapies.

Harrow has completed the acquisition of Melt Pharmaceuticals, which includes product candidates MELT-210, MELT-300, and MELT-400 based on the Zydis ODT (oral dissolving tablet) drug delivery platform.

Twice-weekly intravenous (IV) ketamine over a 4- to 5-week induction period for severe treatment-resistant depression (TRD) was associated with a faster and greater reduction in symptoms than ...

IV Solution & Ketamine Centers of Chicago has released a comprehensive collection of patient testimonial videos documenting successful treatment outcomes for individuals suffering from ...